WallStreetZenWallStreetZen

NASDAQ: EOCN
Eocene Ltd Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their EOCN stock forecasts and price targets.

Forecast return on equity

Is EOCN forecast to generate an efficient return?

Company
N/A
Industry
21.47%
Market
176.3%

Forecast return on assets

Is EOCN forecast to generate an efficient return on assets?

Company
N/A
Industry
23.1%

EOCN earnings per share forecast

What is EOCN's earnings per share in the next 3 years based on estimates from 3 analysts?

Avg 1 year Forecast
-$11.64
Avg 2 year Forecast
-$2.21
Avg 3 year Forecast
-$2.11

EOCN revenue forecast

What is EOCN's revenue in the next 3 years based on estimates from 3 analysts?

Avg 1 year Forecast
$0.0
Avg 2 year Forecast
$193.8k
Avg 3 year Forecast
$1.7M

EOCN vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
EOCN$3.08N/AN/A
ADXN$2.99N/AN/A
DRMA$0.76N/AN/A
ERNA$1.99N/AN/A
ENLV$2.70$1,280.00+47,307.41%Buy
View Top Biotech Stocks

Eocene Stock Forecast FAQ

What is EOCN's earnings growth forecast for 2026-2028?

(NASDAQ: EOCN) Eocene's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 11.38%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 32.75%.

Eocene's earnings in 2026 is -$11,343,000.On average, 3 Wall Street analysts forecast EOCN's earnings for 2026 to be -$11,654,424, with the lowest EOCN earnings forecast at -$11,197,387, and the highest EOCN earnings forecast at -$11,997,201. On average, 3 Wall Street analysts forecast EOCN's earnings for 2027 to be -$2,216,485, with the lowest EOCN earnings forecast at -$2,129,564, and the highest EOCN earnings forecast at -$2,281,676.

In 2028, EOCN is forecast to generate -$2,114,343 in earnings, with the lowest earnings forecast at -$2,031,428 and the highest earnings forecast at -$2,176,530.

If you're new to stock investing, here's how to buy Eocene stock.

What is EOCN's revenue growth forecast for 2026-2028?

(NASDAQ: EOCN) Eocene's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 31.16%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.4%.

Eocene's revenue in 2026 is $0.On average, 3 Wall Street analysts forecast EOCN's revenue for 2026 to be $0, with the lowest EOCN revenue forecast at $0, and the highest EOCN revenue forecast at $0. On average, 3 Wall Street analysts forecast EOCN's revenue for 2027 to be $194,070, with the lowest EOCN revenue forecast at $186,460, and the highest EOCN revenue forecast at $199,778.

In 2028, EOCN is forecast to generate $1,747,433 in revenue, with the lowest revenue forecast at $1,679,338 and the highest revenue forecast at $1,799,505.

What is EOCN's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: EOCN) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 23.1%.

What is EOCN's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: EOCN) Eocene's current Earnings Per Share (EPS) is -$15.12. On average, analysts forecast that EOCN's EPS will be -$11.64 for 2026, with the lowest EPS forecast at -$11.18, and the highest EPS forecast at -$11.98. On average, analysts forecast that EOCN's EPS will be -$2.21 for 2027, with the lowest EPS forecast at -$2.13, and the highest EPS forecast at -$2.28. In 2028, EOCN's EPS is forecast to hit -$2.11 (min: -$2.03, max: -$2.17).

What is EOCN's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: EOCN) forecast ROE is N/A, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.